Brief: Novus Therapeutics Announces Name Change To Eledon Pharmaceuticals
04/01/2021 13:42
Jan 4 (Reuters) - Eledon Pharmaceuticals Inc NVUS.O :
* NOVUS THERAPEUTICS ANNOUNCES NAME CHANGE TO ELEDON
PHARMACEUTICALS; PROVIDES CORPORATE UPDATE AND OUTLOOK
* NOVUS THERAPEUTICS INC - ELEDON TO COMMENCE TRADING ON
NASDAQ
EXCHANGE UNDER TICKER "ELDN" EFFECTIVE JANUARY 5
* NOVUS THERAPEUTICS INC - ELEDON IS WELL FINANCED TO
COMPLETE UP
TO FOUR PHASE 2 CLINICAL TRIALS OF LEAD CANDIDATE AT-1501
Source text for Eikon: ID:nGNX5NMQrG
Further company coverage: NVUS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial